DERMAGO sell "SKINATAN®"

A generic equivalent of Bayer's Advantan, built around methylprednisolone aceponate 0.1% (a fourth-generation topical glucocorticoid), positioned in the D7A plain topical corticosteroid market for dermatitis, atopic dermatitis and contact dermatitis (indication varies by formulation). Skin Care Pharma offers it as a solution (1 mg/ml), emulsion, cream and ointment; the global MPA market reached roughly EUR 84 million in 2020 (IQVIA), Advantan has been off-patent since 2012, and the product is partnered with Galen Pharma in Germany, launched in 2019.